Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Kabra Drugs Financial Results

Kabra Drugs reported a total income of ₹93.23 Crore and a net profit of ₹4.96 Crore for FY2026. The Board approved these audited results today.

Key figures
Value₹93.23 Cr
Source

BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kabra Drugs Ltd: key numbers

Share price
₹16.26
Market cap
₹38.55 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.1×Sector 46.1×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kabra Drugs Ltd

All →

Other financial results announcements

All →